About Cancer Pain Therapeutics

Cancer pain can be acute or chronic, depending on its stages and types. Cancer pain is caused by the tumor pressing against bones, nerves, or other organs in an individuals body. Pain control is imperative not only for people who have advanced cancer but also for those whose condition remains stable for years. Pharmaceutical interventions such as non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and adjuvant pain medications are used to treat cancer pain.

Technavios analysts forecast the global cancer pain therapeutics market to grow at a CAGR of 9.08% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global cancer pain therapeutics market for 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of cancer pain.
The market is divided into the following segments based on region:

Americas: The US, Canada, Mexico, and Brazil
EMEA: The UK, Germany, Italy, France, Spain, Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and the UAE
APAC: Japan, China, Australia, Singapore, South Korea, and India

Technavios report, Global Cancer Pain Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
BioDelivery Sciences
ProStrakan Group
Teva Pharmaceuticals
Yamaha

Global Cancer Pain Therapeutics Market 2015-2019Report Enquiry @ http://www.researchbeam.com/global-cancer-pain-therapeutics-market/enquire-about-report

Table of Contents

PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Market segmentation by product
PART 07: Geographical segmentation
PART 08: Market drivers
PART 09: Impact of drivers
PART 10: Market challenges
PART 11: Impact of drivers and challenges
PART 12: Market trends
Rising use of portable nebulizers
PART 13: Vendor landscape
PART 14: Appendix
PART 15: Explore Technavio

Contact Us
Research Beam
Global Head Quarters
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
Direct: +1 (503) 894-6022
Toll Free: +1 (800) 910-6452
Eail us at: [email protected]
Website: http://www.researchbeam.com/